Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Sort ascending Original Publication Date Journal Bone Marrow Disease
Haploidentical stem cell transplantation (haplo-SCT) represents the main alternative for children with inherited bone marrow failure syndrome (I-BMF) lacking a matched donor. This retrospective study, conducted on behalf of the EBMT SAAWP and PDWP, aims t American Society of Clinical Oncology Educational Book Myelodysplastic Syndromes (MDS)
Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of Bone Marrow Transplantation Aplastic Anemia
Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of Bone Marrow Transplantation Aplastic Anemia
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide Blood Advances Aplastic Anemia
Guideline-based indicators for adult patients with myelodysplastic syndromes Blood Advances Myelodysplastic Syndromes (MDS)
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial The Lancet Haematology Myelodysplastic Syndromes (MDS)
Granulocyte transfusions in severe aplastic anemia Haematologica Aplastic Anemia
Granulocyte transfusions in severe aplastic anemia Haematologica Aplastic Anemia
Good but not good enough: Clinical trial participation of patients with myelodysplastic syndromes Cancer Myelodysplastic Syndromes (MDS)
Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.